| Announce Date | 01/28/2026 |
| EPS Normalized Actual | $8.55 (Miss by $-0.46) |
| EPS GAAP Actual | $8.55 (Miss by $-0.46) |
| Revenue Actual | $7.516B |
| Revenue Surprise | Beat by $7516M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 69.01139 | 20.48 | 64.09592 | 76.3454 | 5 |
| Dec 2029 | 47.65879 | 29.65 | 43.48682 | 50.26226 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.49 | 5.49 | 7.516B | 0.65% | 7516M |
| FQ2 2025 (Jun 2025) | 5.9 | 5.9 | 7.6917B | 18.84% | 7691.7M |
| FQ1 2025 (Mar 2025) | 5.47 | 5.47 | 7.7415B | 31.67% | 7741.5M |
| FQ4 2024 (Dec 2024) | 6.85 | 6.85 | 9.2628B | 21.87% | 9262.8M |
| FQ3 2024 (Sep 2024) | 5.28 | 5.28 | 7.4673B | 10.64% | 7467.3M |
| FQ2 2024 (Jun 2024) | 4.01 | 4.01 | 6.2428B | -10.56% | 6242.8M |
| FQ1 2024 (Mar 2024) | 3.11 | 3.11 | 5.29B | -27.53% | 5290M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 7.237B | 11.15% | 7237M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 13.10025 | -- | 12.18237 | 13.70437 | 8 |
| FQ3 2028 (Sep 2028) | 11.19391 | -- | 10.4096 | 11.71012 | 8 |
| FQ2 2028 (Jun 2028) | 9.38057 | -- | 8.72332 | 9.81315 | 8 |
| FQ1 2028 (Mar 2028) | 8.06706 | -- | 7.50184 | 8.43907 | 8 |
| FQ4 2027 (Dec 2027) | 10.42697 | -- | 9.6964 | 10.90781 | 7 |
| FQ3 2027 (Sep 2027) | 9.19415 | -- | 8.54996 | 9.61814 | 7 |
| FQ2 2027 (Jun 2027) | 8.47999 | -- | 7.88584 | 8.87104 | 7 |
| FQ1 2027 (Mar 2027) | 8.39955 | -- | 7.81103 | 8.78689 | 7 |
| FQ4 2026 (Dec 2026) | 10.07407 | -- | 9.56746 | 10.56161 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 14.13B | -- | 13.37B | 14.63B | 4 |
| FQ3 2028 (Sep 2028) | 12.62B | -- | 11.94B | 13.07B | 7 |
| FQ2 2028 (Jun 2028) | 11.26B | -- | 10.66B | 11.66B | 4 |
| FQ1 2028 (Mar 2028) | 10.12B | -- | 9.57B | 10.48B | 4 |
| FQ4 2027 (Dec 2027) | 12.36B | -- | 11.69B | 12.8B | 10 |
| FQ3 2027 (Sep 2027) | 11.27B | -- | 10.67B | 11.67B | 7 |
| FQ2 2027 (Jun 2027) | 10.59B | -- | 10.02B | 10.97B | 5 |
| FQ1 2027 (Mar 2027) | 10.46B | -- | 9.9B | 10.83B | 5 |
| FQ4 2026 (Dec 2026) | 11.27B | -- | 10.83B | 11.69B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.49 | 5.49 | 100% | |
| FQ2 2025 (Jun 2025) | 5.9 | 5.9 | 100% | |
| FQ1 2025 (Mar 2025) | 5.47 | 5.47 | 100% | |
| FQ4 2024 (Dec 2024) | 6.85 | 6.85 | 100% | |
| FQ3 2024 (Sep 2024) | 5.28 | 5.28 | 100% | |
| FQ2 2024 (Jun 2024) | 4.01 | 4.01 | 100% | |
| FQ1 2024 (Mar 2024) | 3.11 | 3.11 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $7.52B | $7516M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $7.69B | $7691.7M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $7.74B | $7741.5M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $9.26B | $9262.8M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $7.47B | $7467.3M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $6.24B | $6242.8M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.29B | $5290M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $7.24B | $7237M | 100% |